We are currently working to resolve technical issues preventing us from processing applications or payment for membership. Please email Membership on subscriptions@rheumatology.org.uk with any queries.
Search

Overview

COVID-19 resources

Read all of BSR's resources on rheumatology and COVID-19.
COVID-19 guidance

Access our COVID-19 guidance

Read more

New results: persisting impacts of COVID-19 on those with chronic disease

Results of a new survey identify multiple ongoing care barriers related to the pandemic
Find out more

New results: COVID-19 impact on rare autoimmune rheumatic diseases

Higher risks for patients, says researcher Megan Rutter in this updated research
Find out more

Research Funding Call winner: increased risk of COVID-19 and death for those with rare autoimmune rheumatic diseases

Congratulations to Dr Megan Rutter, who's just released an important piece of COVID-19 research
Find out more

COVID-19: research into experiences of lupus patients

Under 30% of patients with lupus and other systemic autoimmune rheumatic diseases felt medically supported during the first wave of the pandemic
Find out more

Supporting clinicians: implementing COVID-19 Green Book recommendations

Pressing to ensure clinically extremely vulnerable patients are offered vaccination before planned immunosuppression
Find out more

Easy access: all of our COVID-19 resources

Need some resources for COVID-19? We've compiled everything we have into one handy news story
Find out more

Arthritis drugs could help save lives of COVID-19 patients

Our perspective on the recent COVID-19 news around tocilizumab and sarilumab
Find out more

COVID-19: managing rheumatology services with reduced capacity

Find out how services can be managed alongside key constraints such as staffing levels
Find out more

COVID-19: risk assessment tools and patient vulnerability

Prof Karen Walker-Bone on recently developed COVID-19 risk assessment tools
Find out more

If you have any queries related to COVID-19 and rheumatology, please email our Policy team, who'll be happy to help.

Get in touch